Target intelligence / Profile preview

Orthodenticle homeobox 1 (OTX1)

Target
OTX1
Molecular classification
Transcription factor, Homeobox protein, DNA-binding protein
01

Overview

Orthodenticle homeobox 1 (OTX1) is a conserved homeodomain-containing transcription factor of the bicoid sub-family that binds DNA and regulates the expression of genes involved in brain and sensory organ development[4][7][11][2]. OTX1 is essential for central nervous system and sensory organ formation; in mouse models, loss of OTX1 can cause brain malformations and epilepsy[4][7]. In humans, OTX1 is overexpressed in multiple cancers, including bladder, breast, colorectal, and liver cancers, where it promotes cell proliferation, cell cycle progression, and tumor cell motility, and its high expression is associated with poor prognosis, particularly in bladder cancer[1]. OTX1 is also linked to neurodevelopmental disorders such as autism spectrum disorder and agnathia-otocephaly complex[4]. No drugs are currently known to specifically target OTX1, but as a regulator of proliferation and differentiation, it is considered a possible therapeutic target and a prognostic biomarker in oncology[1].

Other names
Homeobox protein OTX1Orthodenticle homolog 1OTX1
02

Biological functions

Brain developmentSensory organ developmentRegulation of cell cycleControl of cell proliferationRegulation of cell motilityEmbryonic development
03

Disease associations

Cancer (including bladder cancer, breast cancer, colorectal cancer, hepatocellular carcinoma)EpilepsyAutism spectrum disorderAgnathia-otocephaly complexNeurodevelopmental disorders
04

Safety considerations

Potential risks in modulating neurodevelopmental or proliferative pathways (based on role in brain development and cancer)Precise risks not established
05

Biomarkers

Prognostic biomarker for cancer (notably bladder cancer)

Beyond the preview

Go deeper on Orthodenticle homeobox 1 (OTX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthodenticle homeobox 1 (OTX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call